pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Pred Forte
drug
save

prednisolone acetate

Marketedupdated 3mo ago
by $ABBV AbbVie Inc.
Approved
community read0 votes

🐶 often sniffed alongside

top 3
  • drugPRED MILD74 co-mentions · 37 sources
  • tagApproval74 co-mentions · 37 sources
  • drugprednisolone37 co-mentions · 37 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 11 investigational indications.

all catalysts(37)

approval · 37
Nov 10, 1972
approval
$ABBV249.46-0.54%
54y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Feb 23, 1977
approval
$ABBV249.46-0.54%
50y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Feb 23, 1977
approval
$ABBV249.46-0.54%
50y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Feb 23, 1977
approval
$ABBV249.46-0.54%
50y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Feb 23, 1977
approval
$ABBV249.46-0.54%
50y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Feb 28, 1977
approval
$ABBV249.46-0.54%
49y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Oct 2, 1979
approval
$ABBV249.46-0.54%
47y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Jan 29, 1980
approval
$ABBV249.46-0.54%
47y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Sep 4, 1980
approval
$ABBV249.46-0.54%
46y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Aug 13, 1982
approval
$ABBV249.46-0.54%
44y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Sep 2, 1982
approval
$ABBV249.46-0.54%
44y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Sep 2, 1982
approval
$ABBV249.46-0.54%
44y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Jun 6, 1986
approval
$ABBV249.46-0.54%
40y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Jul 8, 1986
approval
$ABBV249.46-0.54%
40y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Oct 29, 1987
approval
$ABBV249.46-0.54%
39y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Jan 27, 1988
approval
$ABBV249.46-0.54%
39y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Dec 8, 1988
approval
$ABBV249.46-0.54%
38y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Apr 27, 1989
approval
$ABBV249.46-0.54%
37y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Oct 13, 1989
approval
$ABBV249.46-0.54%
37y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Dec 7, 1990
approval
$ABBV249.46-0.54%
36y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Mar 4, 1993
approval
$ABBV249.46-0.54%
33y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Aug 3, 1995
approval
$ABBV249.46-0.54%
31y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Mar 25, 1996
approval
$ABBV249.46-0.54%
30y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Dec 5, 1996
approval
$ABBV249.46-0.54%
30y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Sep 30, 1997
approval
$ABBV249.46-0.54%
29y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
May 8, 1998
approval
$ABBV249.46-0.54%
28y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Oct 2, 2000
approval
$ABBV249.46-0.54%
26y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Apr 12, 2001
approval
$ABBV249.46-0.54%
25y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Sep 19, 2001
approval
$ABBV249.46-0.54%
25y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Dec 4, 2001
approval
$ABBV249.46-0.54%
25y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Apr 12, 2002
approval
$ABBV249.46-0.54%
24y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Mar 19, 2003
approval
$ABBV249.46-0.54%
23y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
May 4, 2017
approval
$ABBV249.46-0.54%
9y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Jun 6, 2018
approval
$ABBV249.46-0.54%
8y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Dec 8, 2022
approval
$ABBV249.46-0.54%
4y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Dec 8, 2022
approval
$ABBV249.46-0.54%
4y ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
Nov 25, 2025
approval
$ABBV249.46-0.54%
9mo ago
PRED MILD (PREDNISOLONE ACETATE) — FDA approval
prednisolone acetate
→
view all 37 catalysts →

Trials studying prednisolone acetate

  • phase2A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expressionrecruitingn=100
  • phase4Dextenza in the Post-op Management of Vitreoretinal Surgeriesrecruitingn=30
  • N/AEthanol Gel Versus Steroid in Refractory Lumbar Discogenic Painrecruitingn=230
  • phase3A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitisnot yet recruitingn=152
  • phase4In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgerycompletedn=30
  • phase4Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataractrecruitingn=60
  • phase2A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitiscompletedn=89
  • phase3Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Populationrecruitingn=60
more trials →

Patent cliff

source: FDA Orange Book
first barrier falls
Oct 11, 2028
~2.2 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (2)

  • Oct 11, 2028formulationUS 77993312.2y
  • Oct 11, 2028formulationUS 77993312.2y

News(0)

no news has mentioned this drug yet

brand
Pred Forte
generic
prednisolone acetate
MOA
Glucocorticoid receptor agonist
indication
Anterior Segment Inflammation
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 2m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?